Plunkett Research Online: Amarin Corporation plc

AMARIN CORPORATION PLC (AMRN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its lead product includes Vascepa......



Amarin Corporation plc
Ticker: AMRN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 353 1 6699 020
Fax:
Address: 112-114 St Stephens Green
Iconic Offices, The Greenway, Block C Ardilaun Court
Dublin, D02 TD28 Ireland

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Cardiovascular
Drugs, Cardiovascular Health
Drugs, Triglyceride Reduction
Pharmaceutical Development
Contacts Description
Patrick HoltCEO/Director/President
Thomas ReillyCFO/Chief Accounting Officer/Secretary
See More
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its lead product includes Vascepa......See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Vascepa
VAZKEPA
REDUCE-IT
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: